Gene · 1672
Papers3,189
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 3,189
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Citrus pectin protects mice from burn injury by modulating intestinal microbiota, GLP-1 secretion and immune response. | Int Immunopharmacol | 2024 | 38522140 | PubTator, text mining | PubMed |
| Successes and challenges in the development of BD1-selective BET inhibitors: a patent review. | Expert Opin Ther Pat | 2024 | 38465537 | PubTator, text mining | PubMed |
| Early skin inflammatory biomarker is predictive of development and persistence of atopic dermatitis in infants. | J Allergy Clin Immunol | 2024 | 38460678 | PubTator, text mining | PubMed |
| ERK1/2-CEBPB Axis-Regulated hBD1 Enhances Anti-Tuberculosis Capacity in Alveolar Type II Epithelial Cells. | Int J Mol Sci | 2024 | 38397085 | PubTator, text mining | PubMed |
| A 14-Day Double-Blind, Randomized, Controlled Crossover Intervention Study with Anti-Bacterial Benzyl Isothiocyanate from Nasturtium (Tropaeolum majus) on Human Gut Microbiome and Host Defense. | Nutrients | 2024 | 38337658 | PubTator, text mining | PubMed |
| Antimicrobial peptides and other potential biomarkers of critical illness in SARS-CoV-2 patients with acute kidney injury. AMPAKI-CoV study. | Physiol Rep | 2024 | 38328863 | PubTator, text mining | PubMed |
| Innate Immunity Activation in Newly Diagnosed Ileocolonic Crohn's Disease: A Cohort Study. | Dis Colon Rectum | 2024 | 38319717 | PubTator, text mining | PubMed |
| Identification of potent BRD4-BD1 inhibitors using classical and steered molecular dynamics based free energy analysis. | J Cell Biochem | 2024 | 38317535 | PubTator, text mining | PubMed |
| Concentration of novel urinary tract infection biomarkers in neonates. | Sci Rep | 2024 | 38316971 | PubTator, text mining | PubMed |
| PM2.5 Causes Increased Bacterial Invasion by Affecting HBD1 Expression in the Lung. | J Immunol Res | 2024 | 38314088 | PubTator, text mining | PubMed |
| Association of tumor budding with clinicopathological features and prognostic value in stage III-IV colorectal cancer. | World J Gastroenterol | 2024 | 38312121 | PubTator, text mining | PubMed |
| Structure-Guided Design and Synthesis of Pyridinone-Based Selective Bromodomain and Extra-Terminal Domain (BET)-First Bromodomain (BD1) Inhibitors. | J Med Chem | 2024 | 38295759 | PubTator, text mining | PubMed |
| Single-cell combined bioinformatics analysis: construction of immune cluster and risk prognostic model in kidney renal clear cells based on CD8+ T cell-associated genes. | Eur J Med Res | 2024 | 38291496 | PubTator, text mining | PubMed |
| Relationship between biofilm-forming microorganisms (BFM: Staphylococcus aureus and Pseudomonas aeruginosa) and DEFB1 gene variants on β-defensin levels in periprosthetic joint infection (PJI). | Mol Biol Rep | 2024 | 38285273 | PubTator, text mining | PubMed |
| Comparison between hangeshashinto and dexamethasone for IL-1α and β-defensin 1 production by human oral keratinocytes. | J Oral Biosci | 2024 | 38278301 | PubTator, text mining | PubMed |
| Establish a novel tumor budding-related signature to predict prognosis and guide clinical therapy in colorectal cancer. | Sci Rep | 2024 | 38273073 | PubTator, text mining | PubMed |
| Oral microbiota, co-evolution, and implications for health and disease: The case of indigenous peoples. | Genet Mol Biol | 2024 | 38259033 | PubTator, text mining | PubMed |
| Multimorbidity of Psoriasis: A Large-Scale Population Study of Its Associated Comorbidities. | J Clin Med | 2024 | 38256625 | PubTator, text mining | PubMed |
| The Impact of IL1B rs1143634 and DEFB1 rs11362 Variants on Periodontitis Risk in Phenylketonuria and Type 1 Diabetes Mellitus Patients in a Latvian Population. | Diagnostics (Basel) | 2024 | 38248068 | PubTator, text mining | PubMed |
| The Genetic Aspects of Periodontitis Pathogenesis and the Regenerative Properties of Stem Cells. | Cells | 2024 | 38247810 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1672/papers?page=9